ClinicalTrials.gg
RecruitingNCT07119515TIPCBT-GADUpdated Aug 13, 2025

Teletherapy vs. In-Person Cognitive Behavioral Therapy for Generalized Anxiety Disorder

An interventional study of Third-Wave CBT via Teletherapy and Third-Wave CBT In-Person in Generalized Anxiety Disorder, sponsored by Government College University Faisalabad. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-08-13.

Sponsored by Government College University Faisalabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The goal of this randomized controlled trial is to compare the clinical efficacy of teletherapy versus in-person third-wave cognitive behavioral therapy (CBT) in treating generalized anxiety disorder (GAD) among young individuals aged 18-45 years in Pakistan. The main questions it aims to answer are:

  • Is teletherapy as effective as in-person therapy in reducing anxiety symptoms and stress?
  • Do therapeutic alliance, treatment adherence, and social support influence treatment outcomes differently across delivery methods? Researchers will compare the teletherapy group (remote sessions via digital platforms) and the in-person therapy group (face-to-face sessions) to evaluate differences in symptom reduction, general health improvement, and moderating factors like therapeutic alliance.

Participants will:

  • Undergo a 8-week intervention with weekly structured third-wave CBT sessions.
  • Complete assessments at baseline, post-intervention, and follow-up using validated scales (e.g., Generalized Anxiety Disorder-7 [GAD-7], Hamilton Anxiety Rating Scale [HAM-A]).
  • Engage in modules including mindfulness, behavioral activation, and exposure therapy, adapted for their assigned delivery method.

This study aims to address gaps in mental health accessibility in Pakistan by evaluating whether teletherapy can serve as a viable alternative to traditional in-person care.

Read the detailed description

This randomized controlled trial (RCT) compares the efficacy of teletherapy versus traditional in-person delivery of third-wave cognitive behavioral therapy (CBT) for treating generalized anxiety disorder (GAD) among adults (aged 18-45 years) in Pakistan. Conducted at Allied Hospital II, Faisalabad, the study will randomize eligible participants(diagnosed via Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision [DSM-5-TR] criteria) into two parallel arms: (1) a teletherapy group receiving 12 weekly sessions via secure video conferencing, and (2) an in-person group attending face-to-face sessions with identical content. Both interventions will follow a standardized third-wave CBT protocol integrating mindfulness, acceptance, and behavioral strategies. Primary outcomes include changes in anxiety severity (measured by Hamilton Anxiety Rating Scale [HAM-A] and Generalized Anxiety Disorder-7 [GAD-7]) and depressive symptoms (Patient Health Questionnaire-9 [PHQ-9]). Secondary outcomes assess perceived stress (Perceived Stress Scale [PSS]), work and social adjustment (Work and Social Adjustment Scale [WSAS]) and therapeutic alliance (Working Alliance Inventory [WAI]). Assessments will occur at baseline, post-intervention, and follow-up. The study aims to address critical gaps in mental healthcare accessibility in resource-limited settings by evaluating whether teletherapy can achieve comparable outcomes to in-person therapy. Ethical approval will be obtained from GCUF's Institutional Review Board (IRB), and the trial adheres to Consolidated Standards of Reporting Trials (CONSORT) guidelines. Results may inform policy decisions to expand remote mental health services in Pakistan.

02

Conditions studied

  • Generalized Anxiety Disorder

Keywords

  • Teletherapy
  • In-person therapy
  • Cognitive behavioral therapy (CBT)
  • Generalized anxiety disorder (GAD)
  • Randomized controlled trial (RCT)
  • Mental health accessibility
  • Anxiety disorders
  • Pakistan
  • Therapeutic alliance
  • Third-wave CBT
  • Remote mental health services
03

In context

Generalized Anxiety Disorder

517 studies on the registry are indexed under Generalized Anxiety Disorder; 124 are open to participants now.

This study's planned enrollment of 25 is below the median of 83 across 439 interventional studies indexed under Generalized Anxiety Disorder.

Browse Generalized Anxiety Disorder studies →

Lead sponsor

Government College University Faisalabad is the lead sponsor of 23 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age ≥18-≤45 years -meeting the diagnostic criteria according to TR -ability to understand and read English -ability to use digital technology and having access to the Internet -signed an form

Exclusion criteria

Exclusion Criteria:

  • the presence of risk of suicide and self-destructive behaviors -presence of another severe mental disorder (i.e., substance abuse, psychotic disorder, or bipolar disorder) -presence of severe personality disorder -presence of a medical condition whose severity or characteristics prevent participation in treatment -receiving another psychological treatment during the study
  • an increase or change in medication during the study period
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Teletherapy

    Behavioral: Third-Wave CBT via Teletherapy

  • Active comparator
    In-Person therapy

    Behavioral: Third-Wave CBT In-Person

Interventions

  • BehavioralThird-Wave CBT via Teletherapy

    Twelve weekly 40-minute remote sessions via video conferencing, including mindfulness, behavioral activation, and exposure therapy.

  • BehavioralThird-Wave CBT In-Person

    Twelve weekly 40-minute face-to-face sessions with identical third-wave CBT content.

06

What researchers measure

Primary outcomes

  1. Hamilton Anxiety Rating Scale (HAM-A)

    A clinician-rated scale assessing anxiety severity. Range: 0-56 (higher scores indicate worse outcomes).

    Time frame: 3 Months

  2. Generalized Anxiety Disorder-7 (GAD-7)

    A 7-item self-report questionnaire measuring anxiety severity. Range: 0-21 (higher scores indicate worse outcomes).

    Time frame: 3 Months

  3. Patient Health Questionnaire-9 (PHQ-9)

    A 9-item self-report tool for assessing depressive symptoms. Range: 0-27 (higher scores indicate worse outcomes).

    Time frame: 3 Months

Secondary outcomes

  1. Perceived Stress Scale (PSS)

    A 10-item self-report measure evaluating perceived stress. Range: 0-40 (higher scores indicate worse outcomes).

    Time frame: 3 Months

  2. Work and Social Adjustment Scale (WSAS)

    A 5-item self-report measure assessing functional impairment in work and social domains. Range: 0-40 (higher scores indicate worse outcomes).

    Time frame: 3 Months

  3. Working Alliance Inventory (WAI)

    A 12-item scale measuring therapeutic alliance between client and therapist. Range: 12-84 (higher scores indicate better outcomes).

    Time frame: 3 Months

07

Study locations

1 of 1 sites recruiting
  • Allied Hospital II
    Faisalabad, Punjab Province 38000, Pakistan
    Recruiting
    • Head Psychologist · Contact+92-321-7605488
    • Imaan Sabeeh, MS Scholar · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) will be made available upon reasonable request to qualified researchers. Data will include baseline characteristics, outcome measures, treatment adherence metrics, and supporting documents such as the study protocol and statistical analysis plan.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be available six months post-publication

Access criteria: Access will be granted to researchers affiliated with academic institutions, non-profit organizations, or governmental agencies for non-commercial research purposes. De-identified IPD (demographics, clinical outcomes, treatment data) and supporting documents (protocol, statistical analysis plan, informed consent template) can be assessed. Data will be accessible after publication of the primary study results.

Data sharing details ↗ · osf.io

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07119515
Lead sponsor
Government College University Faisalabad
Collaborators
Allied Hospital Faisalabad
Responsible party
Imaan Sabeeh (MS Scholar , Department of Applied Psychology, GCUF, Government College University Faisalabad) — Principal investigator
First posted
Aug 13, 2025
Start date
Mar 10, 2025
Primary completion
Aug 26, 2025 (estimated)
Completion
Aug 26, 2025 (estimated)
Last update
Aug 13, 2025

Study contacts

imaan Sabeeh, MS Scholar
Contact
imaansabeeh@gmail.com
+92-309-7000728
Asma Riaz, PHD
Contact
asmariaz@gcuf.edu.pk
+92-334-5154091
Imaan Sabeeh, MS Scholar
principal investigator · Government College University Faisalabad

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion